about
Cyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretionStatins effect on smooth muscle cell proliferation.Do structural differences in statins correlate with clinical efficacy?Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation.Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation.Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells.Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.Free cholesterol alters macrophage morphology and mobility by an ABCA1 dependent mechanismEffect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytesDirect effects of statins on the vascular wallDirect vascular effects of HMG-CoA reductase inhibitorsNitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol
P50
Q27309230-50F2032F-BCD4-4144-9D9D-8CAFBA17DA60Q36110605-9324B15A-B26E-4F33-8528-DF8EAE947C66Q37768005-874E7C35-D60B-471D-890D-757ED4530BC8Q38313076-B51DFCB7-D9C9-4681-8895-DCE9CF5A714CQ40062867-0348A50E-96D2-4971-B269-011AD8754ED5Q42933669-336C2C20-9BCD-4A55-9206-621A1AEC793AQ43234264-F2742AE3-C917-448F-BDFB-414D0FFAC1E3Q43832301-3298BA85-987F-44E0-8D8B-3D2899576E8BQ44730517-E26330DD-2430-4FE4-B92F-EA67E23708FBQ45927404-BB01B269-1DDC-4D0B-A41D-424B38D92ACBQ46235462-2494B3C2-0D84-4324-8BD3-37DC218EBC02Q62029323-0FC55F78-73F4-43C3-88B4-5D53D2AE3249Q71559207-0BAA40A6-AE97-4658-A4F6-01280C03B4B4Q74565877-AD0FF672-8A05-431D-9F56-49D6201CC1B7Q77052081-97A61A39-9313-4950-B087-96C81B4D885AQ86096285-B82604BE-803D-4919-BBDC-E3930575446E
P50
description
researcher ORCID ID = 0000-0002-4017-7631
@en
wetenschapper
@nl
name
Lorenzo Arnaboldi
@ast
Lorenzo Arnaboldi
@en
Lorenzo Arnaboldi
@es
Lorenzo Arnaboldi
@nl
type
label
Lorenzo Arnaboldi
@ast
Lorenzo Arnaboldi
@en
Lorenzo Arnaboldi
@es
Lorenzo Arnaboldi
@nl
prefLabel
Lorenzo Arnaboldi
@ast
Lorenzo Arnaboldi
@en
Lorenzo Arnaboldi
@es
Lorenzo Arnaboldi
@nl
P106
P1153
6602185744
P21
P214
2260152200819814400003
P31
P496
0000-0002-4017-7631
P734
P735
P7859
viaf-2260152200819814400003